This section outlines the experimental workflow used to test and validate the genetic constructs designed for the RDX biosensor project. The experiments aimed to confirm the integrity of the synthesized sequences, establish successful transformation in Escherichia coli, and evaluate the bacterial response to the explosive compound RDX. All steps were carried out under standardized molecular biology and biosafety protocols to ensure accuracy, reproducibility, and safety. The experimental process began when the synthesized DNA sequences were received, containing the riboswitch and reporter elements. These sequences were transformed into E. coli DH5α electrocompetent cells using the electroporation method to generate recombinant bacterial strains carrying the target constructs. Transformed colonies were selected on kanamycin-containing agar plates and later verified for correct base pair length through restriction enzyme digestion and agarose gel electrophoresis. These analytical steps confirmed the expected insert sizes and validated the success of the DNA synthesis and transformation processes. Following verification, the engineered E. coli strains were cultured in M9 minimal medium supplemented with kanamycin and exposed to different concentrations of RDX. The goal was to assess whether the riboswitch could detect and respond to the presence of RDX, generating a measurable reporter signal that reflects biosensor activity. Additionally, protocols for gel extraction and ligation were included as contingency procedures in case the synthesized constructs needed to be subcloned into an alternative vector, such as an iGEM-compatible plasmid. This ensured flexibility for future molecular modifications or standardization with iGEM assembly requirements. Overall, the workflow combines transformation, molecular verification, and biosensor functional testing to evaluate the potential of the riboswitch-based system for RDX detection. The following sections detail the materials, methods, and adapted Standard Operating Procedures (SOPs) applied throughout the experimental process.
* It is important to note that some of the Standard Operating Procedures shown were adapted from already existing ones prepared by undergraduate students working in the Microbial Biotechnology and Bioprospecting Lab (MBBL).
This protocol describes the transformation of plasmids into E. coli DH5α electrocompetent cells using electroporation. The transformed cells are then recovered and plated on selective media for subsequent cryopreservation and downstream applications.
Keep electrocompetent cells, DNA, cuvettes, and SOC on ice at all times.
Note: A loud pop or spark indicates arcing, often due to excess salts in the DNA. Discard and repeat with cleaner DNA.
Restriction digestion is used to cut plasmid DNA at specific recognition sites using restriction enzymes, preparing DNA for cloning, ligation, or analytical applications.
Typical reaction volume: 10 µL (can be scaled).
| Component | Volume (example 10 µL reaction) |
|---|---|
| Plasmid DNA | 100–500 ng (≈1–7 µL, depending on concentration) |
| 10X rCutSmart Buffer | 1 µL |
| Restriction enzyme(s) | 0.5–1 µL each (typically 1–10 units per reaction) |
| Nuclease-free water | To final volume (adjust so total = 10 µL) |
Add components in the following order (to reduce enzyme inactivation):
This protocol describes the isolation of plasmid DNA from E. coli overnight cultures using the alkaline lysis method, followed by precipitation and purification. The resulting DNA can be used for cloning, digestion, or storage.
This protocol describes purification of DNA fragments from low-melting-point agarose gels using β-Agarase I (New England Biolabs). The method ensures recovery of intact DNA for downstream applications such as cloning, ligation, or sequencing.
Agarose gel electrophoresis is used to verify DNA size, analyze genetic material, and check the quality/purity of DNA samples. DNA fragments migrate through agarose in an electric field, and are visualized with a nucleic acid stain. Gel electrophoresis is also an important step for DNA insert separation.
Safety note: Ethidium bromide is mutagenic — handle with PPE and dispose properly or use a safer stain alternative.
DNA inserts with compatible sticky ends are ligated into the plasmid vector using T4 DNA Ligase, following the Ligation Protocol with T4 DNA Ligase by New England Biolabs.
Note: NEB’s ligation calculator or standard molar ratio guidelines can be used to adjust volumes based on DNA sizes and concentrations.
This protocol describes the purification of plasmid DNA from E. coli using the ZymoPURE™ Plasmid Miniprep Kit with the centrifugation method. The kit allows rapid recovery of up to 100 µg of high-quality plasmid DNA suitable for downstream applications including cloning, sequencing, and transfection.
* Note: the next two protocols were done in the Chemistry Department under supervision of licensed personnel in the Center for Chemical Sensors Chemical Imaging and Surface Analysis Center. One of our team members previously did undergraduate research in this lab and she carried out the following protocols.
This protocol describes the preparation of a sterile, accurately quantified 5.00 mM stock solution of RDX (MW = 222.12 g/mol) in acetone at a final volume of 25.00 mL, suitable for experimental use, following institutional safety procedures.
Desired concentration × volume = moles required
\[ 5.00 \, \text{mM} = 0.00500 \, \text{mol/L} \]
\[ \text{Volume} = 25.00 \, \text{mL} = 0.02500 \, \text{L} \]
Moles = concentration × volume
\[ \text{moles} = 0.00500 \, \text{mol/L} \times 0.02500 \, \text{L} \]
\[ \text{moles} = 0.000125000 \, \text{mol} \]
Convert moles to mass using MW of RDX (222.12 g/mol)
\[ \text{mass (g)} = \text{moles} \times \text{MW} \]
\[ \text{mass} = 0.000125000 \, \text{mol} \times 222.12 \, \text{g/mol} \]
\[ 222.12 \, \text{g/mol} \times 0.000125000 \, \text{mol} = 0.0277650 \, \text{g} \]
Conversion
\[ 0.0277650 \, \text{g} \times 1000 \, \text{mg/g} = 27.7650 \, \text{mg} \]
Assess whether E. coli detects RDX when grown in defined medium with antibiotic selection by comparing biological responses across multiple exposure levels and appropriate controls.
| Target [RDX] (µM) | For 6 mL LB Tubes: Volume from 5 mM Stock (µL) | For 6 mL LB Tubes: Volume from 10 mM Stock (µL) |
|---|---|---|
| 0.00 | 0 | 0 |
| 0.10 | 0.1 | 24 |
| 0.30 | 0.4 | 72 |
| 0.44 | 0.50 | 105.2 |
| 0.50 | 0.60 | 120 |
| 1.00 | 1.20 | 240 |
| 2.00 | 2.40 | 480 |
| 3.80 | 4.60 | 912 |
| 4.40 | 5.30 | 1056 |
| 5.00 | 6.00 | 1200 |
| 6.20 | 7.40 | 1488 |
The SOPs listed below were used as the basis for adapting our laboratory protocols and originate from the Microbial Biotechnology and Bioprospecting Lab (MBBL), led by Carlos Ríos-Velázquez.
[1] C. Hernández Guerrero, “Transformation of Escherichia coli electrocompetent cells by electroporation (SOP S1 2024–2025),” unpublished SOP, University of Puerto Rico at Mayagüez, Biology Department, Microbial Biotechnology and Bioprospecting Laboratory, Dec. 2024.
[2] New England Biolabs, “DNA ligation with T4 DNA ligase (Protocol M0202),” [Online]. Available: https://www.neb.com/en/protocols/0001/01/01/dna-ligation-with-t4-dna-ligase-m0202. [Accessed: Oct. 4, 2025].
[3] Universidad de Puerto Rico, Recinto Universitario de Mayagüez, Departamento de Biología, “Manual de genética de bacterias,” Rev. 2020, Lab. 3: Extracción de plásmidos, pp. 21–27, 2020.
[4] New England Biolabs, “DNA purification from agarose gels using β-Agarase I (Protocol M0392),” [Online]. Available: https://www.neb.com/en/protocols/0001/01/01/dna-purification-from-agarose-gels-using-beta-agarase-i-m0392. [Accessed: Oct. 4, 2025].
[5] Zymo Research, “ZymoPURE™ Plasmid Miniprep Kit (Instruction manual, Ver. 2.0.5),” Zymo Research Corp., Cat. Nos. D4208T, D4209, D4210, D4211, D4212, 2023.
[6] iGEM-RUM, “RDX–Riboswitch test protocol,” unpublished manuscript, University of Puerto Rico at Mayagüez, Department of Biology, 2025.